192 related articles for article (PubMed ID: 24571424)
21. Predictors of Long-Term Quality of Life for Survivors of Stage II/III Rectal Cancer in the Cancer Care Outcomes Research and Surveillance Consortium.
Charlton ME; Stitzenberg KB; Lin C; Schlichting JA; Halfdanarson TR; Juarez GY; Pendergast JF; Chrischilles EA; Wallace RB
J Oncol Pract; 2015 Jul; 11(4):e476-86. PubMed ID: 26080831
[TBL] [Abstract][Full Text] [Related]
22. Neoadjuvant Therapy in Rectal Cancer Patients With Clinical Stage II to III Across European Countries: Variations and Outcomes.
Babaei M; Jansen L; Balavarca Y; Sjövall A; Bos A; van de Velde T; Moreau M; Liberale G; Gonçalves AF; Bento MJ; Ulrich CM; Schrotz-King P; Lemmens V; Glimelius B; Brenner H
Clin Colorectal Cancer; 2018 Mar; 17(1):e129-e142. PubMed ID: 29074354
[TBL] [Abstract][Full Text] [Related]
23. Impact of adjuvant chemotherapy after neoadjuvant radio- or radiochemotherapy for patients with locally advanced rectal cancer.
Lichthardt S; Zenorini L; Wagner J; Baur J; Kerscher A; Matthes N; Kastner C; Pelz J; Kunzmann V; Germer CT; Wiegering A
J Cancer Res Clin Oncol; 2017 Nov; 143(11):2363-2373. PubMed ID: 28756493
[TBL] [Abstract][Full Text] [Related]
24. Clinical implications of acellular mucin pools in resected rectal cancer with pathological complete response to neoadjuvant chemoradiation.
de Campos-Lobato LF; Dietz DW; Stocchi L; Vogel JD; Lavery IC; Goldblum JR; Skacel M; Pelley RJ; Kalady MF
Colorectal Dis; 2012 Jan; 14(1):62-7. PubMed ID: 21176057
[TBL] [Abstract][Full Text] [Related]
25. Outcomes of multimodality therapies for patients with stage II or III rectal cancer in California, 1994-2009.
Cho MM; Morgan JW; Knutsen R; Oda K; Shavlik D; Knutsen S; Kazanjian K
Dis Colon Rectum; 2013 Dec; 56(12):1357-65. PubMed ID: 24201389
[TBL] [Abstract][Full Text] [Related]
26. Poor compliance with adjuvant chemotherapy use associated with poorer survival in patients with rectal cancer: An NCDB analysis.
Xu Z; Mohile SG; Tejani MA; Becerra AZ; Probst CP; Aquina CT; Hensley BJ; Arsalanizadeh R; Noyes K; Monson JR; Fleming FJ
Cancer; 2017 Jan; 123(1):52-61. PubMed ID: 27560162
[TBL] [Abstract][Full Text] [Related]
27. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.
Rödel C; Graeven U; Fietkau R; Hohenberger W; Hothorn T; Arnold D; Hofheinz RD; Ghadimi M; Wolff HA; Lang-Welzenbach M; Raab HR; Wittekind C; Ströbel P; Staib L; Wilhelm M; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R; Liersch T;
Lancet Oncol; 2015 Aug; 16(8):979-89. PubMed ID: 26189067
[TBL] [Abstract][Full Text] [Related]
28. Defining the Role of Minimally Invasive Proctectomy for Locally Advanced Rectal Adenocarcinoma.
Sujatha-Bhaskar S; Jafari MD; Gahagan JV; Inaba CS; Koh CY; Mills SD; Carmichael JC; Stamos MJ; Pigazzi A
Ann Surg; 2017 Oct; 266(4):574-581. PubMed ID: 28650357
[TBL] [Abstract][Full Text] [Related]
29. Adjuvant Chemotherapy Is Associated With Improved Overall Survival in Locally Advanced Rectal Cancer After Achievement of a Pathologic Complete Response to Chemoradiation.
Shahab D; Gabriel E; Attwood K; Ma WW; Francescutti V; Nurkin S; Boland PM
Clin Colorectal Cancer; 2017 Dec; 16(4):300-307. PubMed ID: 28420585
[TBL] [Abstract][Full Text] [Related]
30. Is Chemotherapy or Radiation Therapy in Addition to Surgery Beneficial for Locally Advanced Rectal Cancer in the Elderly? A National Cancer Data Base (NCDB) Study.
Bergquist JR; Thiels CA; Shubert CR; Habermann EB; Hayman AV; Zielinski MD; Mathis KL
World J Surg; 2016 Feb; 40(2):447-55. PubMed ID: 26566779
[TBL] [Abstract][Full Text] [Related]
31. Is an elective diverting colostomy warranted in patients with an endoscopically obstructing rectal cancer before neoadjuvant chemotherapy?
Patel JA; Fleshman JW; Hunt SR; Safar B; Birnbaum EH; Lin AY; Mutch MG
Dis Colon Rectum; 2012 Mar; 55(3):249-55. PubMed ID: 22469790
[TBL] [Abstract][Full Text] [Related]
32. Survival among clinical stage I-III rectal cancer patients treated with different preoperative treatments: A population-based comparison.
Joye I; Silversmit G; Van Eycken E; Debucquoy A; Vandendael T; Penninckx F; Haustermans K
Cancer Epidemiol; 2016 Aug; 43():35-41. PubMed ID: 27388565
[TBL] [Abstract][Full Text] [Related]
33. Prospective, longitudinal analysis of the gut microbiome in patients with locally advanced rectal cancer predicts response to neoadjuvant concurrent chemoradiotherapy.
Sun Y; Zhang X; Jin C; Yue K; Sheng D; Zhang T; Dou X; Liu J; Jing H; Zhang L; Yue J
J Transl Med; 2023 Mar; 21(1):221. PubMed ID: 36967379
[TBL] [Abstract][Full Text] [Related]
34. Adjuvant Chemotherapy After Preoperative Chemoradiation Improves Survival in Patients With Locally Advanced Rectal Cancer.
Sun Z; Gilmore B; Adam MA; Kim J; Hsu SD; Migaly J; Mantyh CR
Dis Colon Rectum; 2017 Oct; 60(10):1050-1056. PubMed ID: 28891848
[TBL] [Abstract][Full Text] [Related]
35. Lymph node yield is an independent predictor of survival in rectal cancer regardless of receipt of neoadjuvant therapy.
Xu Z; Berho ME; Becerra AZ; Aquina CT; Hensley BJ; Arsalanizadeh R; Noyes K; Monson JRT; Fleming FJ
J Clin Pathol; 2017 Jul; 70(7):584-592. PubMed ID: 27932667
[TBL] [Abstract][Full Text] [Related]
36. The effect of adjuvant chemotherapy on survival and recurrence after curative rectal cancer surgery in patients who are histologically node negative after neoadjuvant chemoradiotherapy.
Baird DLH; Denost Q; Simillis C; Pellino G; Rasheed S; Kontovounisios C; Tekkis PP; Rullier E
Colorectal Dis; 2017 Nov; 19(11):980-986. PubMed ID: 28493401
[TBL] [Abstract][Full Text] [Related]
37. Neoadjuvant therapy for rectal cancer: histologic response of the primary tumor predicts nodal status.
Read TE; Andujar JE; Caushaj PF; Johnston DR; Dietz DW; Myerson RJ; Fleshman JW; Birnbaum EH; Mutch MG; Kodner IJ
Dis Colon Rectum; 2004 Jun; 47(6):825-31. PubMed ID: 15108025
[TBL] [Abstract][Full Text] [Related]
38. Prognosis factors for recurrence in patients with locally advanced rectal cancer preoperatively treated with chemoradiotherapy and adjuvant chemotherapy.
Arredondo J; Baixauli J; Beorlegui C; Arbea L; Rodríguez J; Sola JJ; Chopitea A; Hernández-Lizoáin JL
Dis Colon Rectum; 2013 Apr; 56(4):416-21. PubMed ID: 23478608
[TBL] [Abstract][Full Text] [Related]
39. The influence of neoadjuvant therapy for the prognosis in patients with rectal carcinoma: a retrospective study.
Li Q; Peng Y; Wang LA; Wei X; Li MX; Qing Y; Xia W; Cheng M; Zi D; Li CX; Wang D
Tumour Biol; 2016 Mar; 37(3):3441-9. PubMed ID: 26449827
[TBL] [Abstract][Full Text] [Related]
40. Impact of Postoperative Chemoradiotherapy versus Chemotherapy Alone on Recurrence and Survival in Patients with Stage II and III Upper Rectal Cancer: A Propensity Score-Matched Analysis.
Song C; Song S; Kim JS; Oh HK; Kim DW; Lee KW; Kim JH; Eom KY; Kim IA; Kang SB
PLoS One; 2015; 10(4):e0123657. PubMed ID: 25902069
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
